Neurovalens Ltd., 7 James St. South
Belfast, BT2 8DN, United Kingdom
NCT Number: NCT04783883
A follow-up assessment study of the long-term safety of vestibular electrical stimulation as delivered by the Vestal DM Device.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Belfast, BT2 8DN, United Kingdom
A retrospective, open-label, follow-up study assessing the long-term safety and efficacy of vestibular electrical stimulation as delivered by the Vestal DM Device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Battery powered non-invasive neurostimulation device (1.5mA)
Time frame: Baseline
Formal audiometry testing to be conducted using the AMTAS Flex Device
Time frame: Baseline
Time frame: Baseline
Photographic inspection of the skin behind the ears to confirm no skin irritation has been caused at the mastoid area where the electrode pads are placed
Time frame: Baseline
Photographs to be taken of both ear canals and both tympanic membranes using the Awelor Wireless Smart Otoscope (Model Number: T1).
Neurovalens Ltd.
Industry
Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Safety Assessment of Long-Term Usage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05142592
Pharmacokinetics, Safety Issues
Portland, Oregon, United States
View Trial DetailsNCT05523596
Safety Issues
Glen Burnie, Maryland, United States
View Trial DetailsNCT05041699
Bleeding, Hemorrhage
Portland, Oregon, United States
View Trial DetailsNCT05518084
Safety Issues
Helsinki, Finland
View Trial Details